Rabeprazole Sodium Salt (CAS 117976-90-6)

Rabeprazole Sodium Salt is the sodium salt form of rabeprazole, a compound classified among proton pump inhibitors (PPIs), which are used for their capability to significantly reduce gastric acid secretion. This chemical operates by selectively and irreversibly binding to the proton pump—the H+/K+ ATPase enzyme system—on the surface of gastric parietal cells. This binding inhibits the final step of hydrochloric acid production within the stomach. In non-clinical research settings, rabeprazole sodium has been utilized to study the effects of acid suppression on the stomach, such as alterations in the gastric microbial environment and the integrity of the gastric mucosal barrier. It also serves as an important tool in pharmacological studies focused on understanding the kinetics and dynamics of acid control. Researchers leverage rabeprazole sodium to compare the efficacy and metabolic characteristics of various proton pump inhibitors, helping to refine their use in managing gastric acidity and to investigate potential systemic effects of long-term acid suppression. These studies contribute to a deeper understanding of gastrointestinal function and the management of disorders associated with excessive gastric acid production.